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Abstract
Background: DNA repair capacity is an important determinant of susceptibility to cancer. The hOGG1 enzyme is
crucial for repairing the 8-oxoguanine lesion that occurs either as a byproduct of oxidative metabolism or as a
result of exogenous sources such as exposure to cigarette smoke. It has been previously reported that smokers
with low hOGG1 activity had significantly higher risk of developing lung cancer as compared to smokers with high
hOGG1 activity.
Methods: In the current study we elucidate the association between plasma levels of 8-OHdG and the OGG1
repair capacity. We used the commercially available 8-OHdG ELISA (enzyme-linked immunosorbent assay), the
Comet assay/FLARE hOGG1 (Fragment Length Analysis by Repair Enzymes) assay for quantification of the levels of
8-OHdG and measured the constitutive, induced and unrepaired residual damage, respectively. We compared the
DNA repair capacity in peripheral blood lymphocytes following H2O2 exposure in 30 lung cancer patients, 30 non-,
30 former and 30 current smoker controls matched by age and gender.
Results: Our results show that lung cancer cases and current smoker controls have similar levels of 8-OHdG lesions
that are significantly higher compared to the non-smokers controls. However, lung cancer cases showed
significantly poorer repair capacity compared to all controls tested, including the current smokers controls. After
adjustment for age, gender and family history of smoking-related cancer using linear regression, we observed a
5-fold increase in risk of lung cancer associated with high levels of residual damage/reduced repair capacity.
Reduced OGG1 activity could be expected to be a risk factor in other smoking-related cancers.
Conclusion: Our study shows that the Comet/FLARE assay is a relatively rapid and useful method for
determination of DNA repair capacity. Using this assay we could identify individuals with high levels of residual
damage and hence poor repair capacity who would be good candidates for intensive follow-up and screening.
Background
DNA repair is a ubiquitous defense mechanism that is
critical to maintaining the integrity of the genome. Sev-
eral prior studies have reported associations between
reduced repair capacity and cancer development [1-3].
Base excision repair (BER) is the main pathway involved
in the repair of oxidative DNA damage and recent stu-
dies have indicated a correlation between reduced BER
capacity and oncogenesis [4,5]. The oxidative DNA
damage induced by reactive oxygen species (ROS) may
lead to single- or double-strand breaks, point and
frame-shift mutations and larger-scale chromosome
abnormalities [6]. ROS can be formed endogenously as
a result of xenobiotic metabolism by cytochrome P450
enzymes, by redox cycling of hormone metabolites or
exposure to other environmental factors [7].
Smoking is an inducer of oxidative stress which results
in ROS-induced DNA damage [8] in the form of DNA
adducts. This may be of particular importance in lung
cancer where increased oxidative DNA damage coupled
with reduced BER may play an important role in modi-
fying the disease risk [9]. It is well know that only a
small percentage of smokers develop lung cancer [10]
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a significant role in the carcinogenic process.
The 8-oxoguanine DNA glycosylase (hOGG1) is one
of the key DNA repair enzymes involved in the BER
pathway in humans [11,12]. It recognizes the 8-oxogua-
nine modifications from both nuclear and mitochondrial
DNA [13]. Among the more than 30 different products
of modified DNA and RNA by oxidative damage [14], 8-
Hydroxy-2’-deoxyguanosine (8-OHdG) is the most
extensively studied induced lesion. 8-OHdG lesion
causes G®Ta n dA ®C transversions [15] that have
been reported as the sites of spontaneous oncogene
expression and ultimately cancer manifestation [16,17].
Deletion of the hOGG1 gene was shown to be asso-
ciated with accumulation of 8-OHdG lesion and
increase in mutational risk [18]. OGG1 deficiency in
yeast was shown to result in a spontaneous mutator
phenotype [19]. Collins et al observed a lack of repair
activity on a DNA substrate containing 8-OHdG protein
extracts from homozygous OGG1 knockout mouse
embryonic fibroblasts [20]. In contrast, mammalian cells
over-expressing OGG1 repair 8-OHdG more rapidly
after toxic insult with oxidants [21]. Increased levels of
8-OHdG has been associated with an increased risk of
lung cancer among smokers [22]. In a recent study, Paz-
Elizur et al evaluated the enzymatic OGG1 activity
among smoking lung cancer cases and controls. The
authors reported that the OGG1 activity was signifi-
cantly decreased in lung cancer cases, and that the risk
of developing lung cancer in smokers with low OGG1
activity was significantly higher compared to smokers
with high OGG1 activity [23]. To date, the association
between the levels of 8-OHdG and OGG1 repair capa-
city has not been determined.
In the current study we hypothesized that an inverse
association exists between the levels of 8-OHdG and
OGG1 activity. Furthermore, we hypothesized that lung
cancer patients have higher levels of 8-OHdG reflecting
suboptimal OGG1 repair capacity when compared to
healthy controls. To test these hypotheses, we quantified
the levels of 8-OHdG and measured ROS-induced DNA
damage and repair in peripheral blood lymphocytes of
lung cancer cases and controls. We used the commer-
cially available 8-OHdG ELISA (enzyme-linked immu-
nosorbent assay) to measure the levels of 8-OHdG in
plasma and the Comet assay and hOGG1 FLARE (Frag-
ment Length Analysis by Repair Enzymes) assay to mea-
sure the constitutive, induced and unrepaired residual
damage by measuring DNA strand breaks and abasic
sites. The Comet assay is used to detect DNA damage
(including single-strand breaks, double-strand breaks
and alkali-labile sites) [24,25] as well as to determine
interindividual variation in DNA repair capacity through
the measurement of residual DNA damage after
exposure to mutagens [26,27]. The hOGG1 FLARE is a
modified Comet assay that employs 8-oxoguanine DNA
glycosylase to recognize and nick the DNA specifically
at the 8-OHdG lesion thus resulting in strand breaks
[28]. Cells not exposed to hOGG1 serve as a baseline
for naturally occurring DNA breaks; while cells exposed
to hOGG1 contain both naturally occurring breaks in
DNA, as well as breaks caused by hOGG1 at places con-
taining unrepaired 8-OHdG adducts [29]. Our results
show that lung cancer cases and current smoker con-
trols had higher levels of 8-OHdG compared to the for-
mer and non-smokers controls. Similarly, our results
demonstrated that baseline DNA damage is comparable
between lung cancer cases and current smoker controls
but is significantly higher than that observed among for-
mer smokers and non-smokers controls. Further investi-
gation revealed that lung cancer cases showed
significantly poorer repair capacity than that observed in
current smoker controls suggesting impairment of
adduct removal. In conclusion, our study shows that the
Comet/FLARE assay is a relatively rapid and useful
method for determination of DNA repair capacity and
that adduct removal by OGG1 is a mechanism that
might be significantly impaired among smokers who
develop lung cancer. Using this assay we could poten-
tially identify individuals with high levels of residual
damage and hence poor repair capacity. Identification of
the small percentage of susceptible smokers with poor
repair would allow for better prevention interventions.
Methods
Study population
A total of 120 participants were included in the study.
Thirty smoker lung cancer patients were recruited from
The University of Texas M. D. Anderson Cancer Center
as part of an ongoing lung cancer case-control study.
The patients had newly diagnosed, histologically con-
firmed lung cancer with no prior history of treatment
(radiation or chemotherapy) upon enrollment in the
study. Controls (n = 90) were matched to cases on age
(+/-5 years) and gender and were recruited from the
Kelsey-Seybold Clinics in Houston, Texas. The control
participants consisted of 30 non-smokers, 30 former
smokers and 30 current smokers with no previous his-
tory of cancer. After informed consent was obtained, a
personal interview was conducted and information
regarding socio-demographics, smoking history, alcohol
consumption, occupational exposures, diet and family
history of cancer was collected. There were no age and
gender restrictions for study eligibility. The institutional
review boards at both M. D. Anderson Cancer Center
and Kelsey-Seybold Clinic approved this study. After
providing informed consent, 10-mL blood was collected
from all study participants.
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Peripheral blood and lymphocytes were isolated using
standard Ficoll-Histopaque method. Briefly, 10 ml of
whole blood from each subject was drawn into heparinized
tubes, layered over 10 ml of Histopaque -1077 (Sigma
Aldrich Co., St. Louis, MO) at room temperature and cen-
trifuged at 1500 rpm for 30 min. The mononuclear cells
were removed from the interphase, washed twice with
phosphate-buffered saline pH 7.2 and centrifuged at 1500
rpm for 10 min. Cells were suspended in 1 ml of RPMI
1640 medium and the cell membrane integrity was deter-
mined by Trypan Blue solution 0.4% and adjusted to a
concentration of 1 × 10
6 cells/ml. Duplicate lymphocyte
cultures were prepared for each study subject. Lympho-
cytes were then resuspended in RPMI 1640 medium sup-
plemented with 1% L-glutamine, 100 U/ml of penicillin
and of streptomycin (Gibco Invitrogen Corp., Grand
Island, NY), 10% fetal calf serum, 2% PHA (Murex Biotech
Ltd., Dartford, England, UK) and cultured in 24-well
microplates for 24 h at 37°C in 5% CO2 prior to treatment.
Establishment of hydrogen peroxide (H2O2) treatment
conditions
We used H2O2 as the ROS-inducing agent in vitro. In
order to establish the optimal conditions for exposure and
repair kinetics, peripheral blood lymphocytes were isolated
from 20 healthy controls. A dose-response curve was gen-
erated using in vitro treatment of lymphocytes with H2O2
(at a range of concentrations between 20-100 μM) for 15
min. Results from the dose response curve indicated that
the 60 μM concentration, lead to a cell viability >85% and
DNA damage that was significantly higher than the nega-
tive control (P < 0.001) (Additional file 1, Figure S1A).
The cells concentration was adjusted to 3 × 10
4 cells/
ml and suspended in RPMI 1640 medium without FBS,
supplemented with 2 mM L-glutamine, 100 U/ml of
penicillin/streptomycin and 20% Alamar Blue cell assay
™(BioSource International Inc., Camarillo, CA, USA) to
determine metabolic activity/cell viability of the cells.
The cell viability was measured for each time of treat-
ment with a spectrophotometer (Tecan, Genios Pro) at
535 nm excitation and 590 nm emission. Using Pear-
son’s correlation we estimated the correlation between
the most common parameters reported in the literature
to determine damage by the Comet assay namely: the
tail extent moment (TEM) and the tail length (TL). Our
results indicated a pair-wise correlation of R
2 = 0.94-
0.96 (P < 0.001) and therefore in the following sections
we reported our findings using the TEM only.
Optimization of recovery time for H2O2-induced damage/
repair
A normal lymphoblastoid cell line (AH, [cat#GM14520],
Coriell Cell Repositories, Camden, NJ, USA) was used
to determine the optimal incubation time for recovery
of in vitro H2O2-induced damage. Significant DNA
damage TEM was observed after 15 min H2O2-treat-
ment as compared to the untreated cells (mean + SD =
0.89 + 0.18 versus 0.47 + 0.07 respectively, P = 0.002).
After 1 h incubation at 37°C to allow the cells to
recover, a significant reduction in TEM was observed as
compared to the H2O2-treated cells (mean ± SD = 0.65
± 0.11 versus 0.89 ± 0.18 respectively, P = 0.007); how-
ever the damage was still significantly higher than that
observed in the untreated cells (mean + SD = 0.65 +
0.11 versus 0.47 + 0.07 respectively, P = 0.01). Incuba-
tion of the cells for 2 h at 37°C showed a further reduc-
tion in the level of measured TEM when compared to
the 1 h incubation (mean ± SD = 0.51 ± 0.05 versus
0.65 ± 0.11, respectively); however these differences
were not statistically significant and we therefore
decided to use the one-hour incubation in our subse-
quent experiments in order to accommodate the further
experimental procedures that included a further incuba-
tion with the hOGG1 enzyme followed by denaturation
and electrophoresis (Additional file 1, Figure S1B).
Measurement of 8-OHdG levels
Baseline serum levels of 8-OHdG was measured using
the commercially available 8-OHdG ELISA Kit (BIOXY-
TECH® OXIS International Inc., Foster City, CA, USA)
following manufacturer’s recommendations. This kit is a
competitive ELISA for quantitative measurement of 8-
OHdG in tissue, serum or plasma resulting from oxida-
tive damage to DNA.
Comet/FLARE® assay
Collins et al [20] first introduced this technique to study
BER pathway. The principal of this assay depends on
incubating cell extracts with a substrate of DNA con-
taining specific lesions. Incubation of the substrate DNA
with the specific enzymes allows for the uncovering of
specific damaged bases. Treating lysed, immobilized
cells with a DNA glycosylase, converts the base to an
alkali sensitive site, followed by DNA unwinding that
allows additional damage to be recognized. This leads to
the introduction of breaks that are measured using the
single-cell gel electrophoresis (Comet) assay. On the
basis of the initial results, the lymphocytes were treated
with a concentration of 60 μMH 2O2 in a total volume
of 200 μM RPMI at 4°C for 15 min. Cells were then
incubated at 37°C for 1 h to allow the cells to recover.
The cell suspension was then aspirated from the wells
and washed with PBS pH 7.2. Cells were then embedded
in a layer of low melting point agarose (LMA) at 37°C
prepared in PBS and the mixtures were immediately
transferred to the FLARE®-slides (Trevigen Inc.). Dupli-
cate slides were prepared from each well. Slides were
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pH 10, 10 mM Tris base, 1% sodium lauryl sarcosinate,
1% Triton X-100 and 1% DMSO) (Trevigen Inc.) for 1 h
at 4°C. The slides were washed in FLARE buffer
(250 mM HEPES-KOH pH 7.4, 2.5 M KCl and 250 mM
E D T A )a tr o o mt e m p e r a t u r et h r e et i m e so v e ra1 5m i n
period. 100 μl of hOGG1 (1:500) was then added to
each sample and incubated at 37°C for 40 min (follow-
ing manufacturer’s recommendations) to allow for
further cell recovery. The DNA of the nuclei in the
agarose gels was denatured in electrophoresis buffer pH
12.1 (3 M NaCl, 500 mM EDTA) for 30 min at 4°C.
Electrophoresis was performed in alkaline solution pH
13 applying 300 mA, 25 V for 30 min at 4°C. The slides
were then placed in cold methanol for 20 min, dried
and stored in a slide box at room temperature. At time
of analysis, the slides were hydrated in cold water at 4°C
for 20 min and stained with ethidium bromide solution
(2 μg/mL). Slides were coded in order to blind the treat-
ment conditions from the scorer and 100 random cells/
sample were analyzed (50 cells/duplicate slide) using an
epi-fluorescence microscope (Nikon) equipped with
Comet IV® software (Perceptive Imaging, Haverhill, Suf-
folk, UK). The mean values of the TEM in each cell
were computed for each experimental group.
Statistical analysis
Descriptive statistics were used to characterize the cases
and controls. Analysis of variance (ANOVA) was used
to compare age and other continuous variables and the
Chi-square test was used to compare the categorical
variables. For the FLARE assay, the Percent Residual
DNA Damage (PRD) was calculated using the following
equation:
PRD=XH2O2+OGG−XH2O2XH2O2×100. Where
XH2O2 is the mean TEM values for each study subject
after treatment with H2O2, while XH2O2 +O G Gis the
mean TEM values for each study subject after H2O2
treatment and further incubation with OGG1 enzyme
for removal of additional residual damage. Linear regres-
sion analysis was conducted to adjust the TEM H2O2 +
OGG1 by TEM H2O2. The residual values from the
regression defined as Residual Damage Linear Regres-
sion (RDLR) among the cases and controls were com-
puted using ANOVA. RDLR was dichotomized using
the 75
th percentile of the controls and estimates of lung
cancer risk (OR and 95% CL) for RDLR adjusted for
age, sex and family history of a smoking related cancer
were determined.
Results
Demographics and the study population
The demographic characteristics of the 30 cases and 90
controls are summarized in Table 1. No significant
differences were observed between cases and the con-
trols did not differ significantly in terms of age, gender
or ethnicity. Fifty-two percent of the patients self-
reported a family history of smoking-related cancer,
compared with 40% of the current, 59% of the former
and 50% of the non-smoker controls (P = 0.07). Cases
had on an average smoked cigarettes for 44.23 years,
compared with 42.70 and 35.37 years for current and
former smoker controls (P > 0.05 and P < 0.001, respec-
tively); however both cases and controls (current and
former groups) smoked about the same number of
cigarettes per day (mean number of cigarettes per day ±
SE for cases = 29.2 ± 2.5 and 24.4 ± 1.75 and 35.0 ± 3.3
for current and former smokers respectively, P = 0.10).
Measurement of 8-OHdG levels at baseline by ELISA
Among controls, the current and former smoker con-
trols showed significantly higher levels as compared to
non-smoker controls (mean ± SE, 1.99 + 0.55 ng/ml,
1.68 + 0.99 ng/ml versus 0.83 + 0.62 respectively, P <
0.001). There was no significant difference between the
level of 8-OHdG among the former and current smo-
kers controls (P = 0.28). Lung cancer cases had over 2-
fold higher levels of 8-OHdG than the non-smoker con-
trols (mean ± SE, 2.09 + 0.91 ng/ml versus 0.83 + 0.62,
P < 0.001); however the difference was not significant
when compared to former and current smoker controls
(P = 0.88 and P = 0.33, respectively).
Measurement of DNA damage at baseline by Comet
assay
Table 2 shows the extent of baseline DNA damage mea-
sured as TEM. Among controls, the non- and former
smokers had significantly lower DNA damage than the
current smoker controls (mean ± SE = 0.26 ± 0.11 and
0.23 ± 0.09 versus 0.54 ± 0.15, P < 0.001). There was no
significant difference between the level of baseline DNA
damage among the non- and former smokers controls
(P = 0.95).
Comparing cases and controls, the baseline levels of
DNA damage was significantly different between groups
(0.57 ± 0.12 versus 0.35 ± 0.19, P < 0.001). However,
when the controls were subdivided by smoking status,
the levels of TEM were significantly different between
lung cancer cases and non- and former smoker controls
only (P < 0.001). There was no difference between the
level of baseline DNA damage among the current smo-
ker controls and the lung cancer cases (mean ± SE =
0.54 ± 0.15 versus 0.57 ± 0.12 respectively, P = 0.83).
Measurement of H2O2-induced DNA damage by Comet
assay
Level of H2O2-induced DNA damage after an hour
incubation (to allow cellular intrinsic repair of damage)
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groups of controls was significantly different with mean
+ SD = 3.2 + 0.82; 5.8 + 0.31 and 10.2 + 0.93 for non-
former and current smoker controls, respectively. Lung
cancer cases had over 6-, 3-and 1-fold higher levels of
induced DNA damage than the non-, former and cur-
rent smoker controls, respectively. The lung cancer
cases had the highest level of DNA damage followed by
the current smokers (mean + SD = 19.5 + 0.41 versus
10.2 + 0.93, P < 0.001). The non-smokers exhibited the
least damage (mean + SD = 3.2 + 0.82 versus 5.8 + 0.31,
10.2 + 0.93, P < 0.001, for former and current smoker
controls, respectively).
Measurement of DNA repair and residual capacity by
FLARE assay
To elucidate the underlying mechanisms underlying the
differences in response between the lung cancer cases
and the current smoker controls, we used the FLARE
assay to measure the repair capacity between the 2
groups. The TEM measured by the FLARE assay is the
end result of the H2O2-induced damage as well as a
manifestation of the removal of additional 8-oxoG
lesions recognized by the hOGG1 enzyme. Thus the
FLARE can be used to measure the residual damage
that has not been removed during the initial one hour
recovery after H2O2 treatment. Lung cancer cases had
over 2-fold higher levels of DNA damage than the cur-
rent smoker controls (mean ± SD = 44.6 ± 0.89 versus
18.4 ± 1.37, P < 0.001). The residual DNA damage
among cases and current smoker controls are summar-
ized in Table 3. Comparing cases and current smokers
controls revealed significantly lower levels of residual
DNA damage in the controls (P < 0.001), thus reflecting
more efficient repair capacity compared to the cases.
Figure 1 shows the range of calculated DNA repair
capacity in response to H2O2 treatment (Figure 1A) and
H2O2 + hOGG1 (Figure 1B) among cases and current
smokers controls using the 75
th percentile of the con-
trols as the cutoff point. Minimal variation in repair was
observed among the cases, with about 90% and 100% of
the cases falling into the poor repair group (<20%) in
response to H2O2 treatment alone and H2O2 + hOGG1
treatments, respectively. Only 1% of the cases showed a
repair capacity over 80%. In contrast, the current con-
trols had a wide range of repair, with 76% of the control
subjects having a repair capacity of >80% in response to
the H2O2 treatment and H2O2 + hOGG1 treatments.
Table 2 shows the distribution of residual damage
among cases and current controls and determination of
Table 1 Comparison of demographic and clinical factors among cases and controls
Cases Controls
Current
Smokers
Former
Smokers
Non-
Smokers
P-value
N=3 0 N=3 0 N=3 0 N=3 0
Age (mean ± SE) 62.7 ± 0.57 63.5 ± 0.84 61.9 ± 0.69 58.6 ± 0.98 0.27
Gender: N (%)
Male 15(50.0) 20(66.7) 21(70.0) 20(66.7)
Female 15(50.0) 10(33.3) 9(30.0 10(33.3) 0.58
Ethnicity
Anglo 30(100.0) 29(96.7) 25(83.3) 30(100.0)
Non-Anglo 0(0.0) 1(3.3) 5(16.7) 0(0.0) 0.24
No. of Cigarettes/day Mean ± SE 29.2 ± 2.5 24.4 ± 1.75 35.0 ± 3.3 0.0 ± 0.0 <0.001
Years smoked Mean ± SE: 44.23 ± 1.39 42.70 ± 1.46 35.37 ± 1.58 0.0 ± 0.0 <0.001
Family History Cancer
N (%)
No 14(48.3) 15(60.0) 12(41.4) 15(50.0)
Yes 15(51.7) 10(40.0) 17(58.6) 15(50.0) 0.07
P-values from Chi-square test for association (categorical) or ANOVA (continuous)
Table 2 Distribution of baseline and H2O2-induced DNA damage among cases and controls
Controls Cases P-value
Tail Extent Moment
Mean ± SE
Non-
Smokers
Former
Smokers
Current
Smokers
Current Smokers
Baseline DNA damage 0.26 ± 0.11 0.23 ± 0.09 0.54 ± 0.15 0.57 ± 0.12 <0.001
H2O2- induced DNA damage 3.2 ± 0.82 5.8 ± 0.31 10.2 ± 0.93 19.5 ± 0.41 <0.001
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and family history of a smoking-related cancer using lin-
ear regression there was a 5-fold increase in risk of lung
cancer associated with high levels of residual damage or
reduced repair capacity (OR = 5.07; 97% CL = 1.80-
14.24).
Discussion
DNA damage generated by ROS produced as bypro-
ducts of cellular metabolism has been proposed as a key
factor in mutagenesis and cancer process. Superoxide
(O2
-), hydrogen peroxide (H2O2), and the hydroxyl radi-
cal (OH
-) are mutagens produced as byproducts of nor-
mal metabolism in mitochondria and by ionizing
radiation [7]. ROS can induce single-strand breaks and
several types of DNA base damage, including fragmen-
ted, ring-opened forms and oxidized aromatic deriva-
tives. Among many repair pathways, the BER pathway is
the most important cellular protection mechanism
responding to oxidative DNA damage induced by ROS
[5]. Therefore, increased oxidative DNA damage and
reduced BER capacity may play an important role in
lung carcinogenesis.
OGG1 is a critical component of the BER pathway
required for the removal of 8-OHdG lesion from DNA
exposed to ROS. The impaired repair activity of OGG1
protein was suggested to be a factor contributing to the
high somatic mutation rate in human cells, since the
accumulation of 8-OHdG cause mutations by mis-pair-
ing with adenine during replication [11-14]. It has also
been reported that lower enzymatic levels of OGG1 in
peripheral lymphocytes correlated with an increased risk
of lung cancer among smokers [23]. In our current
study, we elucidate the association between plasma
levels of 8-OHdG and the OGG1 repair capacity among
lung cancer cases and controls.
Our results demonstrated that baseline DNA damage
is similar among lung cancer cases and current smoker
controls and is significantly higher than that observed
among the former and non-smokers controls. These
findings are consistent with other studies showing
higher levels of constitutive DNA damage in the form of
spontaneous chromosomal aberrations and elevated
endogenous single-stranded breaks [30-32] among
patients compared to controls. Results from the baseline
serum levels of 8-OHdG followed a similar pattern to
Table 3 Distribution of DNA damage and percent residual DNA damage among cases and current smoker controls
Tail Extent Moment
Mean ± SE
Cases Controls P-value Adjusted
OR
95% CL
Current
Smokers
Current
Smokers
H2O2 + OGG1 44.6 ± 0.89 18.4 ± 1.37 <0.001
Percent Residual Damage (PRD) 237.4 ± 8.7 180.8 ± 50.7 <0.001
Residual Damage Logistic Regression (RDLR)
≤75th N (%) 13(43.3) 41(75.9
>75th N (%) 17(56.7) 13(24.1)
5.07 1.80-14.24
Referent 5.07 1.80-14.24
P-value from t-test; TEM RDLR dichotomized by 75
th percentile of the controls. Adjusted by age, sex and family history of a smoking-related cancer
Figure 1 Range of calculated DNA repair capacity measured as
TEM among cases and current smoker controls. A) Percentage
of DNA repair capacity among current smoker controls and lung
cancer cases, after treatment with H2O2. B) Percentage of DNA
repair capacity among current smoker controls and lung cancer
cases, after treatment with H2O2 + hOGG1.
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current smoker controls had the highest levels of 8-
OHdG as compared to the former smokers; however,
these differences were not significant. Interestingly, the
levels of 8-OHdG were significantly lower among non-
smoker controls as compared to the lung cancer cases
and current smoker controls. These findings are consis-
tent with studies that have reported that smoking-
induced DNA adducts persist for a long time and could
still be detectable long after quitting [33,34]. Moreover,
numerous reports have associated radicals with smok-
ing-related oxidative stress and DNA damage [23,35,36]
since the metabolic activation process leads to the for-
mation of DNA adducts, which are carcinogen metabo-
lites bound covalently to DNA, usually at guanine or
adenine. If DNA adducts escape cellular repair mechan-
isms and persist, they may lead to miscoding, resulting
in a permanent mutation. Using a linear regression
model we elucidated whether the increase in 8-OHdG
levels in cancer patients is related to the increase in resi-
dual damage by hOGG1 FLARE among smokers. A sig-
nificant correlation, (P < 0.02) was found between high
levels of 8-OHdG levels at baseline and high levels of
residual damage.
Lung cancer is a logical disease for evaluating oxida-
tive damage and the role of free radicals because the
etiologic agents for lung cancer are tobacco carcinogens
that are known to damage DNA. We therefore used
H2O2 as the ROS-inducing agent in lymphocytes of lung
cancer patients and controls in order to measure differ-
ential sensitivity (reflected by level of induced DNA
damage) and variation in repair capacity. H2O2 under-
goes a Fe (II)-mediated Fenton reaction in the cell,
resulting in the formation of the highly reactive hydroxyl
radical and other reactive oxygen species which can
induce strand breaks in the DNA [37]. Several studies
have shown that the repair of single-strand breaks in
normal cells is generally rapid, occurring within one
hour from exposure [38,39] which is in agreement with
results from our DNA repair time course (Additional
file 1, Figure S1B). In our experiments, treatment of the
cells with H2O2 followed by a one-hour incubation (to
allow strand breaks repair) showed that the level of
induced DNA damage was significantly different in all
four groups studied, with 3.36-and 1.76-fold increases in
detected DNA damage in the cancer cases and current
smoker controls respectively as compared to former
smoker controls. These results indicate that the periph-
eral lymphocytes from the three comparison groups
may have differential sensitivity to H2O2 with the lung
cancer patients being more sensitive than the current
and former smoker controls.
In addition to the increase in sensitivity to H2O2-
induced damage, the lung cancer cases may have a poorer
repair capacity than either group of current smoker con-
trols. Several case-control studies have reported that low
DNA repair capacity is an independent risk factor for sev-
eral types of cancers [27,40,41]. Likewise, several studies
have shown similar increases in DNA damage and
decreases in repair efficiency in response to in vitro treat-
ment with chemical mutagens [42-44]. In the current
study, H2O2 treatment followed by a one-hour incubation
with hOGG1 enzyme allowed the quantification of the
level of residual 8-oxoG in DNA and determination of the
repair capacity in the two groups. Our results showed that
current smoker controls had a significantly lower level of
residual DNA damage compared to the cases. After adjust-
ment for age, gender and family history of a smoking-
related cancer using linear regression there was a 5-fold
increase in risk of lung cancer associated with high levels
of residual damage/reduced repair capacity (OR = 5.07;
97% CL = 1.80-14.24). Reduced OGG1 activity could be
expected to be a risk factor in other smoking-related can-
cers. However, given the abundance of 8-oxoguanine and
the suspected role of oxidative stress in cancer, reduced
OGG1 activity might be associated with the risk of some
other cancers as well. The excision of 8-oxoguanine resi-
dues by OGG1 protects against aberrant adenine-cytosine
and guanine-thymine conversions [15] that can lead to
heritable mutagenesis, particularly in non-proliferative
cells in which lesions accumulate by cell division [45].
OGG1 expression therefore preserves genomic integrity,
and it has been shown that Ogg1-deficient mice
experience enhanced incidences of mutations and tumor
formation [46].
Furthermore, our results showed that the current
smoker controls had a relatively wide range of repair
capacity (Figures 1A and 1B) as compared to the cases,
the majority of which fell in the poor repair category.
Reduced repair capacity of a particular repair protein
may only be revealed when expressed in adverse cellular
conditions under oxidative stress. The major risk factor
for lung cancer is tobacco smoke and a suboptimal
DNA repair could play a crucial role in the susceptibility
of the disease. Using the FLARE assay, we were able to
identify the small percentage of current smoker controls
with poor repair who would be good candidates for
intensive follow-up and screening.
Conclusion
In summary, results from this study suggest that high
levels of 8-OHdG are correlated with high levels of oxi-
dative DNA residual damage and suboptimal OGG1
repair capacity all of which were predominantly seen in
the lung cancer case group. A limitation of our study is
the relatively small sample size of the study groups.
However, given the striking differences in damage and
repair capacities between groups, it is unlikely that the
El-Zein et al. BMC Cancer 2010, 10:439
http://www.biomedcentral.com/1471-2407/10/439
Page 7 of 9effect is due to the sample size. Large prospective stu-
dies are therefore warranted in which robust functional
assays such as the ones used in our study could contri-
bute to the identification of individuals. Such an
approach, which may be extended to include additional
DNA repair pathways, may provide an effective strategy
for the prevention of tobacco-related cancers. The sim-
plicity, rapidity and sensitivity of the FLARE assay make
it a valuable tool for screening and possibly for prioritiz-
ing potential cases for intensive surveillance.
Additional material
Additional file 1: Supplementary results. Figure S1: A) Mean cell
viability in response to different concentrations of H2O2. B) Repair over
time in a normal cell-line after 60 μM treatment with H2O2.
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